Attention:
Card image cap

American Rescue Plan Act Changes to the Affordable Care Act Marketplaces, Medicaid, CHIP, and COBRA


Level: Advanced
Runtime: 93 minutes
Recorded Date: April 20, 2021
Click here to share this program
Printer-Friendly Version
Closed Caption

Agenda

  • Overview of American Rescue Act
  • Expansion of Affordable Care Act Subsidies
  • Process for Obtaining Enhances Subsidies
  • Subsidies for COBRA Continuation Coverage
  • Expanding Medicaid and CHIP Coverage
Runtime: 1 hour, 33 minutes
Recorded: April 20, 2021

Description

Join this in-depth discussion of the new rules affecting ERISA health benefits under the December 2020 and March 2021 federal stimulus bills. The panelists will discuss the new COBRA premium subsidy under the American Rescue Plan Act of 2021 (ARPA), including what health plans are covered, what individuals are eligible for the subsidy, during what time frame, and common questions regarding implementation.

This program was recorded on April 20th, 2021.

Provided By

American Bar Association
Card image cap

Panelists

Card image cap

David Ermer

Managing Member
Ermer & Suter, PLLC

Mr. Ermer is a managing partner of the firm. Since entering private practice in 1979, he has developed substantial expertise in litigating labor, employment discrimination, and employee benefits matters at both the trial and appellate levels. He also has been responsible for providing legal counsel to ERISA-governed single-employer health and welfare plans, to jointly trusted Taft-Hartley pension and health and welfare plans, to voluntary employee beneficiary associations, and to several Federal Employees Health Benefits Plans. Through this work, he has become well versed in current topics in the employee benefits and government contracts fields. He has developed extensive expertise in government contract cost allow ability and cost accounting issues and HIPAA administrative simplification issues. He leads monthly discussion groups for Federal Employees Health Benefits Plan executives and for lawyers interested in that field. He currently maintains a FEHBlog on health care policy issues affecting Federal Employees Health Benefits Plans.

Card image cap

Katie Keith

Professor
Georgetown Law School

Katie Keith, J.D., M.P.H., serves as part-time research faculty for the Center on Health Insurance Reforms. She also is a principal at Keith Policy Solutions, LLC where she advises nonprofits and foundations on health care issues and conducts original legal, policy, and qualitative analysis to support policy goals. Her work includes an emphasis on implementation of the Affordable Care Act and its impact on underserved populations, such as the LGBT community.

Katie is a co-founder and steering committee member of Out2Enroll, a national initiative to connect LGBT people with coverage options under the Affordable Care Act. She is also an appointed consumer representative to the National Association of Insurance Commissioners and an adjunct professor at the Georgetown University Law Center where she teaches courses on the Affordable Care Act and LGBT health law and policy. She also provides “Following the ACA” rapid response analysis for the Health Affairs blog.

Katie received her law degree from Georgetown University Law Center and holds a Master’s in Public Health from Johns Hopkins University.

Card image cap

Sara Rosenbaum

Professor
George Washington University Milken Institute School of Public Health

Sara Rosenbaum is the Harold and Jane Hirsh Professor of Health Law and Policy and Founding Chair of the Department of Health Policy, George Washington University School of Public Health and Health Services. She also holds a Professorship by Courtesy in the law school and is a member of the faculty of the School of Medicine and Health Sciences.

A graduate of Wesleyan University and Boston University Law School, Professor Rosenbaum has devoted her professional career to issues of health justice for populations who are medically underserved as a result of race, poverty, disability, or cultural exclusion. An honored teacher and scholar, a highly popular speaker, and a widely read writer on many aspects of health law and policy, Professor Rosenbaum has emphasized public engagement as a core element of her professional life, providing public service to six presidential administrations and 15 Congresses since 1978. With respect to public engagement and health policy practice, Professor Rosenbaum is best known for her work on the expansion of Medicaid, the expansion of community health centers, patients’ rights in managed care, civil rights and health care, and national health reform. Between 1993 and 1994, Professor Rosenbaum worked for President Bill Clinton, directing the drafting of the Health Security Act and designing the Vaccines for Children program, a landmark law offering near-universal coverage of vaccines for low income and medically underserved children. Professor Rosenbaum also regularly advises many state governments on matters of health policy.

Professor Rosenbaum is the leading author of Law and the American Health Care System, 2d ed., published by Foundation Press, May, 2012, a landmark textbook that explores in depth the interaction of American law and the U.S. health care system. She has received numerous national awards for her work, serves on many organizational and foundation boards, and advises the federal government on national health policy. She is a member of the CDC Director’s Advisory Committee, the CDC Advisory Committee on Immunization Practice (ACIP), and a Commissioner on the Medicaid and CHIP Payment and Access Commission (MACPAC), which advises Congress on federal Medicaid policy.


Card image cap

Similar Courses

Card image cap
74 minutes
Anatomy of a Pharmaceutical Bankruptcy Case
This panel will present a primer on the U.S. pharmaceutical industry, focusing on the typical capital structures of pharmaceutical/development companies versus in-pipeline companies. The panelists will examine the factors leading to the recent surge in pharmaceutical bankruptcy cases and their outcomes/resolutions, as well as ? 363 sales of pharmaceutical companies’ assets and restructurings. Opiate bankruptcy cases such as Purdue and Mallinckrodt will be highlighted, as will ancillary issues that arise in pharmaceutical bankruptcy cases, such as product recalls, regulatory issues (such as with the FDA) and IP licensing issues.

American Bankruptcy Institute

$95

Add to Cart
Card image cap
58 minutes
Bad Faith Insurance: Legal Risks and Imperative Actions to Take
Listen as experienced insurance coverage litigators Michelle L. Burton (Burton Kelley, LLP) and Steven L. Miracle (Meissner Tierney Fisher & Nichols S.C.) provide the audience with an in-depth discussion of the recent regulatory trends surrounding bad faith insurance practices. Speakers, among other things, will offer practical tips and litigation strategies in this rapidly evolving legal climate.

The Knowledge Group

$75

Add to Cart
Card image cap
76 minutes
But I’m Afraid of Needles: The Sale of Health Care Assets
This panel will discuss various issues and challenges accompanying sales of health care assets, including factors to consider in determining whether or not a sale is the best alternative. Such factors include the role of regulatory authorities, political challenges, reimbursement issues, issues related to urban vs. rural facilities, the evolution of the health care business, and best practices in navigating such challenges.

American Bankruptcy Institute

$95

Add to Cart
Card image cap
60 minutes
Cannabis in the Workplace: Workers' Comp and Employee Use
This seminar will look at a number of issues related to the use of medical marijuana for workers’ comp injuries, considerations and coverage questions for insurers, provide answers for employers on applying drug policies and look at other risks for employees, employers and insurers in the workplace.

Property Casualty 360

$65

Add to Cart
Previous Next